H1 Influenza Vaccine(Vaxess Technologies)

N/A

Report date: 2026/03/31 20:00:21

Base Information

Drug NameH1 Influenza Vaccine(Vaxess Technologies)

Drug Alias NameH1 Influenza Vaccine Delivered by VX-103 (a MIMIX Microneedle Array Patch (MAP) System)H1 influenza antigen(Vaxess Technologies)H1 Influenza Vaccine Delivered by MIMIX MAP

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesVaxess Technologies Inc Centricity Research Icon Plc +[4]

China Registration ClassN/A

Develop Information

Active CompaniesCentricity Research Vaxess Technologies Inc

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A